Regadenoson stress in patients with asthma and COPD: A breath of fresh air

Journal of Nuclear Cardiology

Volumn 19, Issue 4, 2012, Pages 647-648

  Thompson, Randall C ^a  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; ADENOSINE A2B RECEPTOR; ADENOSINE RECEPTOR; AMINOPHYLLINE; CORTICOSTEROID; DIPYRIDAMOLE; DOBUTAMINE; REGADENOSON;

ASTHMA; BRONCHOSPASM; CARDIOLOGY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CORONARY ARTERY BLOOD FLOW; DISEASE SEVERITY; DRUG CONTRAINDICATION; EDITORIAL; FORCED EXPIRATORY VOLUME; HIGH RISK POPULATION; HUMAN; NUCLEAR MEDICINE; OXYGEN SATURATION; PATIENT SAFETY; PERFUSION WEIGHTED IMAGING; PHARMACOLOGIC STRESS TESTING; PRIORITY JOURNAL; SAMPLE SIZE; UNSPECIFIED SIDE EFFECT;

ADENOSINE A2 RECEPTOR ANTAGONISTS; ASTHMA; FEMALE; HUMANS; MALE; MYOCARDIAL PERFUSION IMAGING; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PURINES; PYRAZOLES;

EID: 84865083371     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-012-9565-2     Document Type: Editorial

References (8)

1. Polosa R, Rorke S, Holgate ST. Evolving concepts on the value of adenosine hyper-responsiveness in asthma and chronic obstructive pulmonary disease. Thorax 2002;57:649-54.
2. Henzlova MJ, Cerqueira MD, Taillefer R, Mahmarian JJ, Yao SS. Quality Assurance Committee of the American Society of Nuclear Cardiology. Stress protocols and tracers. J Nucl Cardiol 2009. doi: 10.1007/s12350-009-9062-4.
3. Leaker BR, O'Connor B, Hansel TT, et al. Safety of regadenoson, an adenosine A2A receptor agonist for myocardial perfusion imaging, in mild asthma and moderate asthma patients: A randomized, double blind, placebo-controlled trial. J Nucl Cardiol 2008;15:329-36.
4. Thomas GS, Tammelin BR, Schiffman GL, et al. Safety of regadenoson, a selective adenosine A2A agonist, in patients with chronic obstructive pulmonary disease: A randomized, doubleblind, placebocontrolled trial (RegCOPD trial). J Nucl Cardiol 2008;15:319-28.
5. Prenner BM, Bukofzer S, Behm S, Feaheny K, McNutt BE. A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease. J Nucl Cardiol 2012. doi: 10.1007/s12350-012-9547-4.
6. Eagle KA, Boucher CA. Intravenous dipyridamole infusion causes severe bronchospasm in asthmatic patients. Chest 1989;95:258-9.
7. Ranhosky A, Kempthorne-Rawson J, the Intravenous Dipyridamole Thallium Imaging Study Group. The safety of intravenous dipyridamole thallium myocardial perfusion imaging. Circulation 1990;81:1205-9.
8. Cerqueira MD, Verani MS, Schwaiger M, Heo J, Iskandrian AS. Safety profile of adenosine stress perfusion imaging: Results from the Adenoscan Multicenter Registry. J Am Coll Cardiol 1994;23:384-9.